Navigation Links
QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes
Date:11/5/2007

NEW YORK, Nov. 5 /PRNewswire/ -- QED International Associates Inc, administrator for the HealthShares(TM) Exchange-Traded Funds, a series of 20 underlying fund portfolios, today announced that effective at the opening of trading on Wednesday November 7, 2007 BioSphere Medical Inc. (Nasdaq: BSMD) will replace Kyphon INC. (Nasdaq: KYPH), in the HealthShares(TM) Cardio Devices Index, The Corin Group (LSE: CRG.L) will replace KYPH in the HealthShares(TM) Orthopedic Repair Index, and LiveCell Corp, (Nasdaq: LIFC) will replace KYPH in the HealthShares(TM) Composite Index. Kyphon is being acquired by Medtronic Inc (NYSE: MDT).

Companies included in the Cardio Devices Index engage in the manufacture, distribution, and commercialization of medical devices for the treatment of cardiac, vascular, and endovascular disorders and diseases, including but not limited to stents, valves, patches, pumps, defibrillators, pacemakers, sutures and sensors/ chips.

Companies included in the Orthopedic Repair
'/>"/>

SOURCE QED International Associates Inc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...m The Healy Law Firm secure the highest pool-relat...endered an incomplete quadriplegic. , ..., 2009 -- A Cook County jury has entered an $8.1 m...enter, 22 years old at the time, who dove into a s...plegic. The verdict, which was reduced to $4,051,...
(Date:11/30/2009)...(NASDAQ OMX Copenhagen: “EXQ”) announc...wood Screening Facility (ICCB-L) has been recogniz...ICCB-L supports investigators at Harvard Medical S...for high-throughput screening of small molecule an...n, MA and Copenhagen, Denmark (PRWEB) November 30,...
(Date:11/30/2009)...vember 30 Simbionix USA Corporatio...tion systems, in collaboration,with GORE Medical P...dio(TM),workshop for the first time at the upcomin...he Simbionix PROcedure Rehearsal Studio(TM) is the...ans to create practice scenarios based on their,pa...
(Date:11/30/2009)... revealed that beverage can pull-tabs were being s...anufacturers to stay-tabs. But a study presented t...iety of North America (RSNA) found that the new ta...riving factors leading the change in beverage can ...ent swallowing of the pull-tab and potential relat...
(Date:11/30/2009)...stern Medical Center researchers have found that i...ations associated with asthma. The findings, avail...cs, suggest that interventions by parent mentors ...d specialized topical training can effectively re...ts and missed adult workdays. , "Childhood asthm...
Breaking Medicine News(10 mins):Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 2Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 3Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 4Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Beverage can stay-tabs pose swallowing risk 2Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2
...aries widely from state to state, with some states...stroke prevalence of others , according to a new r...vention (CDC). The report, "Prevalence of Stroke -...0 states, the District of Columbia and U.S. territ...
...n Malloy, critically injured in a car accident, sk...l her story. Doctors call her recovery a miracle....Her skull separated from her spine, although her s...ontrol over her head. Surgeons said her injur...
...am of researchers from the University of East Angl...-Planck Institute for Biogeochemistry have found ...rbon dioxide has reached a saturation point. ...has led to a release of stored CO2 into the atmosp...
...tandard regimen in most cancer treatments. Since i...re made to replace it with something more comfort...that LHRH agonists like the drug Zoladex switch of...king the action of a naturally occurring substance...
...as found that intake of cruciferous vegetables wit...otective benefit against bladder cancer. ...ciferous vegetables such as broccoli, cauliflower,...on of cytochrome p450 enzyme levels and provoke ap...
...ly affects to work, sleep and performance of other...r your memory and your concentration. Thi...nd Saifudin Rashiq at the University of Alberta. ...tients, two-thirds of whom showed significant disr...
Other Medicine News:Health News:Significant Differences in Stroke Prevalence Among U.S. States & Territories - CDC Report 2Health News:30-year-old Woman Survives 'internal Decapitation' 2Health News:A Fresh Alternative to Painful Chemotherapy Developed in UK 2Health News:Risk of Bladder Cancer Reduced by Broccoli and Cauliflower 2Health News:Chronic Pain can Impair Memory and Concentration 2
(Date:11/29/2009)..., , CHICAGO, Nov. 29 A...g of the Radiological Society of North America (RS...ace in Chicago , Siemens Healthcare will introduc...ventional oncology at booth #825, East Building/...ly invasive procedures for cancer therapy, the...
(Date:11/29/2009)..., , IOWA CITY, Iowa and ST. LOUIS, Nov. 2...loper of quantitative imaging software for the adv...dical Technologies, a leader in minimally invasive...nounced the companies have signed a definitive agr... of an endobronchial lung navigation and biopsy sy...
(Date:11/29/2009)..., , CHICAGO, Nov. 29 Stimula...ket leadership Fujifilm Medical Systems USA announ...erica (RSNA) annual meeting, the formation of its ... Networks Systems, this new group will integrate a...tics offering and creates a platform for future gr...
Breaking Medicine Technology:Minimally Invasive Procedure for Oncology 2Minimally Invasive Procedure for Oncology 3Minimally Invasive Procedure for Oncology 4Minimally Invasive Procedure for Oncology 5VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 1Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 2Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 3Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 4MRI Might Find Early Alzheimers 55180 1MRI Might Find Early Alzheimers 55180 2Trust in a teardrop 9687 1Trust in a teardrop 9687 2
...TON, N.J., March 25, 2007 /PRNewswire/ -- Once-dai...ation tolvaptan, a,vasopressin receptor antagonist...mptoms of acutely decompensated heart failure (ADH... care, without an,adverse effect on their long-ter...the short- and long-term analyses of the,internati...
...leeding in Patients Treated for Acute Coronary Syn...ne Year, NEW ORLEANS, March 26, 2007 /PRNewswire/ ...l show that acute coronary syndrome,(ACS) patients...t,group had similar rates of ischemic clinical out...apy, confirming previous findings,which showed si...
Other Medicine Technology:Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 2Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 4Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 5Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 6
Protector Collar
Serpentine Cervical Collar
...ipital Mandibular Immobilizer) A completely adjust...ral or hypertension positioning and immobilization...™ collar and a halo-type brace.,Mandibular ...ovable chin plate allows for patient eating and hy...
Ezy Wrap® Economy Contour Cervical Collar
Medicine Products: